Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/12/2003US20030108562 Administering gag protein; vaccines for human immunodeficiency virus
06/12/2003US20030108561 Core-glycosylated HCV envelope proteins
06/12/2003US20030108560 Chimeric filovirus glycoprotein
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108558 Anticholesterol agents; rheumatic diseases; mutiple sclerosis; antidiabetic agents; administering protein extracted from animal liver
06/12/2003US20030108557 Biosynthesis; contacting plant cell with genetic engineered nucleic acid virus; gene expression of fusion protein; splitting using cyanogen bromide
06/12/2003US20030108554 GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003US20030108552 Genetic engineered polypeptides; rheumatic diseases, sepsis, viricides
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108549 Methods and compositions for modulating interleukin-21 receptor activity
06/12/2003US20030108547 Methods of inhibiting the binding of a CD8+ T cell to a class I MHC employing a modified beta 2 microglobulin
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003US20030108544 Compositions and methods for the diagnosis and treatment of tumor
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108539 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
06/12/2003US20030108531 Genes for transfection into bony tissues
06/12/2003US20030108524 Vectors for expressing multiple transgenes
06/12/2003US20030108523 Controlling proliferation of mesothelioma cells; anticancer agent
06/12/2003US20030108521 Adenovirus protein IX, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
06/12/2003US20030108520 Insecticides; genetic engineered polypeptide
06/12/2003US20030108518 TRX1 antibody and uses therefor
06/12/2003US20030108517 Membrane-bound cytokine compositions and methods of modulating an immune response using same
06/12/2003US20030108516 Death domain containing receptor 4
06/12/2003US20030108483 Non-invasive localization of a light-emitting conjugate in a mammal
06/12/2003US20030106798 Factor VIII separation
06/12/2003CA2473883A1 Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469524A1 Adipocyte differentiation-related gene and protein
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
06/12/2003CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway
06/12/2003CA2469151A1 Immunocytokines with modulated selectivity
06/12/2003CA2469134A1 Novel peptide and pharmaceutical use of the same
06/12/2003CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003CA2468944A1 Migration of hematopoietic stem cells and progenitor cells to the liver
06/12/2003CA2468907A1 Effectors of innate immunity
06/12/2003CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
06/12/2003CA2468701A1 T-bet compositions and methods of use thereof
06/12/2003CA2468432A1 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases
06/12/2003CA2466413A1 Flavivirus ns1 subunit vaccine
06/12/2003CA2462966A1 Factor viii c2 domain variants
06/11/2003EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody
06/11/2003EP1318198A1 Process for producing a recombinant polypeptide involving the addition of an inhibitor of chymotrypsins to the cell culture medium
06/11/2003EP1318194A1 Method of screening hypoglycemic substance by using stat inhibitory factor-1
06/11/2003EP1318142A1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
06/11/2003EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
06/11/2003EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
06/11/2003EP1317561A2 Modulation of homologous recombination with single stranded dna binding proteins
06/11/2003EP1317559A2 Dna transfection system for the generation of infectious influenza virus
06/11/2003EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
06/11/2003EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
06/11/2003EP1317544A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof
06/11/2003EP1317543A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
06/11/2003EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/11/2003EP1317540A2 Imidazoline receptor homologs
06/11/2003EP1317538A1 Novel compounds
06/11/2003EP1317537A2 G-csf analog compositions and methods
06/11/2003EP1317536A2 Tnf receptor-like molecules and uses thereof
06/11/2003EP1317532A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
06/11/2003EP1317527A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
06/11/2003EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine)
06/11/2003EP1317487A2 Caveolin peptides and their use as therapeutics
06/11/2003EP1317486A1 Interferon-alpha induced gene
06/11/2003EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
06/11/2003EP1317484A2 VARIANTS OF i PHLEUM PRATENSE /i ALLERGENIC PROTEINS
06/11/2003EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides
06/11/2003EP1317482A1 Nucleotide sequences coding for the ccsb gene
06/11/2003EP1317481A2 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
06/11/2003EP1317480A2 Rabbit hemorrhagic disease vaccine and antigens
06/11/2003EP1317479A2 Methods and compositions for diseases associated with amyloidosis
06/11/2003EP1317478A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II
06/11/2003EP1317477A2 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers
06/11/2003EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/11/2003EP1317473A1 17 human secreted proteins
06/11/2003EP1317472A1 17 human secreted proteins
06/11/2003EP1317471A1 21 human secreted proteins
06/11/2003EP1317470A1 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy
06/11/2003EP1317469A1 21 human secreted proteins
06/11/2003EP1317468A1 23 human secreted proteins
06/11/2003EP1317467A1 7 human secreted proteins
06/11/2003EP1317310A1 Use of serum response factor (srf) modulator for treating srf related diseases
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
06/11/2003EP1317276A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
06/11/2003EP1317275A1 Medicament comprising a dna sequence which codes for the rna-binding koc protein, and comprising a koc protein or a dna sequence of the koc promoter
06/11/2003EP1317274A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging
06/11/2003EP1126874B1 Multicomponent meningococcal vaccine
06/11/2003EP1114060B1 Process for producing peptides from biological fluids and peptides obtainable by said process
06/11/2003EP0848755B1 Vegf-related protein
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003EP0690873B1 Growth differentiation factor-8
06/11/2003EP0665886B1 Cyclin complex rearrangement and uses related thereto
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use
06/11/2003EP0539492B1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423698A The Genome of the HIV-1 inter-subtype (C/B') and use thereof
06/11/2003CN1423697A Virulence genes and proteins and their use
06/11/2003CN1423660A Antibodies
06/11/2003CN1423659A Recombinant gelatins
1 ... 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 ... 2916